Categories: News

Outset Medical to Report Third Quarter 2021 Financial Results on Wednesday, November 3, 2021

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of 2021 after the close of trading on Wednesday, November 3, 2021.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Leslie Trigg, Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Wednesday, November 3, 2021. Interested parties may access the live teleconference by dialing (833) 614-1409 for domestic callers or (914) 987-7130 for international callers, followed by conference ID: 7975557. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contacts

Lynn Lewis or Brian Johnston

Gilmartin Group

investors@outsetmedical.com

Staff

Recent Posts

OSSIO Launches Small OSSIOfiber® Suture Anchors, Expanding Best-in-Class Portfolio of Bio-Integrative, Metal-Free Implants to Improve Soft Tissue Fixation

‘The future of orthopedics’WOBURN, Mass.--(BUSINESS WIRE)--#biointegrative--OSSIO Inc., a fast-growing medical technology company focused on evolving…

1 hour ago

Bennett Blau Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group

NEW YORK--(BUSINESS WIRE)--Evercore (NYSE: EVR) announced today that Bennett Blau has joined the firm as…

1 hour ago

Home Run! Adia Med of Winter Park’s AHCA Triumph Brings Insurance-Covered Healing to Patients

Winter Park, Florida--(Newsfile Corp. - June 16, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), a…

2 hours ago

Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy

First Patients Expected to be Enrolled This MonthHalifax, Nova Scotia--(Newsfile Corp. - June 16, 2025)…

2 hours ago